TC Biopharm (Holdings) Plc
TCBPY
$0.3548
$0.039812.64%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.38M | -4.45M | -2.51M | -4.21M | -3.89M |
| Total Depreciation and Amortization | 119.50K | 121.50K | 152.10K | 161.10K | 179.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 1.80K |
| Total Other Non-Cash Items | 180.70K | 183.60K | 156.50K | 980.30K | 371.20K |
| Change in Net Operating Assets | -671.80K | -682.60K | -1.25M | 16.70K | 1.04M |
| Cash from Operations | -4.76M | -4.83M | -3.45M | -3.05M | -2.30M |
| Capital Expenditure | -27.40K | -27.80K | -26.30K | -- | 30.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -9.00K | -9.20K | -11.60K | -7.10K | -25.10K |
| Cash from Investing | -36.40K | -37.00K | -37.90K | -7.10K | 5.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.06M | 4.06M | 2.79M | 1.01M | 1.37M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -182.70K | -182.70K | 0.00 | -74.00K | 799.40K |
| Cash from Financing | 4.96M | 5.04M | 3.51M | 1.18M | 2.70M |
| Foreign Exchange rate Adjustments | -33.20K | -33.70K | -- | -- | -69.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 135.30K | 137.50K | 29.50K | -1.88M | 337.90K |